Jordan Spencer Carter, MD

Baron JA, Chelius M, Singh G, Schad MD, Berger M, Chong ER, Thomas CJ, Carter JS, Cook MR, Nasta SD, Landsburg DJ, Barta SK, Svoboda J, Schuster SJ, Yegya-Raman N, LaRiviere MJ, Plastaras JP, Chong EA, Hubbeling H Safe Integration of Radiation Therapy With Bispecific Antibodies in Relapsed/Refractory B-cell Lymphomas. , Clin Lymphoma Myeloma Leuk: 2026

Thomas CJ, Myers CS, Chung J, Landsburg D, Nasta SD, Svoboda J, Chong EA, Schuster SJ, Carter J, Cook M, Tomasulo E, Elghawy O, LaRiviere M, Hubbeling H, Plastaras JP, Rook AH, Villasenor-Park J, Ruella M, Kim E, Barta SK. Clinical features and outcomes of patients with non-erythrodermic mycosis fungoides with high blood tumor burden. , Blood Neoplasia: 2026

Schneider M, Paruzzo L, Stella F, Noll JH, Ho M, Babatunde V, Ho B, Devi P, Chong EA, Barta SK, Nasta SD, Svoboda J, Carter J, Cook MR, Hossain NM, Thomas CJ, Patel V, de Souza VB, Alkhatib MH, Li Z, Tan M, Michener P, Guruprasad P, Imparato A, Carturan A, Porazzi P, Fraietta JA, Schuster SJ, Maillard I, Ruella M, Landsburg DJ. Naïve CD4+ T-cells and disease status at CART infusion correlate with clinical outcomes in real-world large B-cell lymphoma patients receiving second-line CAR T therapy. , Nat Commun: 2026

Jiang C, Hoover T, Baron J, Han X, Li B, Gao Y, Kim M, Hubbeling H, Chong EA, Carter J, Svoboda J, Schuster SJ, Landsburg DJ, Nasta SD, Plastaras J, LaRiviere M. Long Term Results of Proton Therapy in Adult Infradiaphragmatic Lymphoma. , Int J Part Ther.: 2026

Landsburg DJ, Musoke N, Gentile C, Brooks TR, Nasta SD, Barta SK, Carter JS, Chong EA, Svoboda J, Schuster SJ, Thomas CJ, Tomasulo EB, Cook MR, Morrissette JJD, Caimi PF, Hill BT. Prognostic impact of TP53 alterations in cases of newly diagnosed large B-cell lymphoma. , Leukemia: 2026

Carter J, von Reusner JM, Sellmyer MA, Bagg A, Barta SK Common Lymphoma in an Uncommon Location , Am J Hematol, 100(8): 2025,1437-1439

Dave NK, Carvajal V, Watts AC, Carter JS, Cook M, Thomas C, Tsai DE, Schuster SJ, Gerson JN, Barta SK, Svoboda J, Chong EA, Hwang WT, Landsburg DJ, Nasta SD. Outcomes at a single institution with MTR induction and consolidation in the management of primary CNS lymphoma , Blood Neoplasia, 16(2): 2025

Frosch ZAK, Meshack C, Meeker C, Varshavsky-Yanovsky A, Khanal R, Bromberg M, Chandar A, Quien E, Carter J, Nakhoda SK, Messmer M, Montgomery C, Incorvati JA, Ali ND, Styler MJ, Fang CY. "I Missed My Other Oncologist": Established Relationships as Barriers and Facilitators to Accessing CAR-T and Autologous Transplantation , Cancer Med.: 2025

Elghawy O, Yang AG, Sussman JH, Thomas CJ, Carter JS, Landsburg DJ, Svoboda J, Kim E, Rook AH, Chung J, Villasenor-Park J, Plastaras JP, LaRiviere M, Hubbeling H, Chelius M, Nasta SD, Chong EA, Schuster SJ, Barta SK. Retrospective cohort study of novel oral agents lenalidomide and duvelisib for relapsed or refractory mycosis fungoides and Sézary syndrome , J Am Acad Dermatol: 2025

Elghawy O, Wang J, Leung OJ, Swami N, Carvajal V, Yang G, Landsburg DJ, Svoboda J, Nasta SD, Chong EA, Schuster SJ, Thomas CJ, Carter JS, Bagg A, Barta SK. Clinical Impact of Next-Generation Sequencing of T-Cell Lymphomas: A Single Institution Experience , Clin Lymphoma Myeloma Leuk.: 2025